ScripBayer AG has reinforced its position as a leader in the radiopharmaceuticals field by inking a deal with the UK's Bicycle Therapeutics, plc that could be worth up to $1.7bn. The firms are teaming u
ScripRatio Therapeutics, Inc. is on a mission to address a broad range of solid tumors through the development of therapeutic and imaging products based on two unique technologies, one of which has already